Instrumento Inactivo

Acciones Islet Sciences Inc OTC Bulletin Board

Acciones

Precio de cierre OTC Bulletin Board Otros sitios de cotización
- ^USD	-

Islet Sciences, Inc. Publishes Data Supporting Remogliflozin Etabonate as a Potential Treatment for NAFLD and NASH	04/05/15
Islet Sciences, Inc. Presented at 50th International Liver Conference	23/04/15
Islet Sciences, Inc. COO to Present at Metabolic Leaders Forum	24/03/15
Islet Sciences, Inc. COO to Present at EASL: Remogliflozin Etabonate as Novel Treatment for Non-alcoholic Steatohepatitis (NASH)	09/03/15
Islet Sciences, Inc. Confirms Issuance of U.S. Patent for Using SGLT2 Inhibitors to Treat NASH/NAFLD	05/03/15

Sector

	Varia. 1 de ene.	Capi.
IQVIA HOLDINGS INC.	+1,77 %	42,86 mil M
LONZA GROUP AG	+46,00 %	41,36 mil M
MODERNA, INC.	+12,24 %	42,74 mil M
CELLTRION, INC.	-8,83 %	27,68 mil M
ICON PUBLIC LIMITED COMPANY	+7,44 %	25,15 mil M
ALNYLAM PHARMACEUTICALS, INC.	-23,01 %	18,63 mil M
MEDPACE HOLDINGS, INC.	+30,56 %	12,37 mil M
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1,82 %	11,92 mil M
UNITED THERAPEUTICS CORPORATION	+8,35 %	11,21 mil M